麦角新碱在宫缩乏力性产后出血治疗中的价值-国际医药研究前沿-CSCIED科技核心评价数据库-手机版

麦角新碱在宫缩乏力性产后出血治疗中的价值

The value of ergometrine in the treatment of postpartum hemorrhage caused by uterine atony

ES评分 0 浏览量：806 下载量：0

DOI	10.12208/j.imrf.20220182
刊名	国际医药研究前沿 International Medical Research Frontier
年，卷(期)	2022, 6(5)
作者	马雅欣*,
作者单位	沧县医院河北沧州 ;
摘要	分析宫缩乏力性从产后出血患者使用麦角新碱的效果。方法从2020年1月-2022年1月期间因宫缩乏力性产后出血入院的患者内随机选择70例，依据治疗形式分组，即实验与对照，各组35例。对照组病患均使用缩宫素，实验组病患则联合麦角新碱，对比效果。结果实验组中产妇术中出血、术后出血控制以及产后整体恢复效果比对照组产妇更佳，凝血功能指标高于对照组，两组比较有差异性，P＜0.05。实验组疗效优于对照组，P＜0.05。结论对宫缩乏力性产后出血患者实施麦角新碱治疗，可提升疗效，改善症状，减少出血量。
Abstract	Objective: To analyze the effect of ergometrine on postpartum hemorrhage due to uterine atony. Methods: from January 2020 to January 2022, 70 patients with postpartum hemorrhage due to uterine atony were randomly selected and grouped according to the treatment form, namely, experiment and control, with 35 patients in each group. The patients in the control group were treated with oxytocin, and the patients in the experimental group were treated with ergometrine to compare the effects. Results: the control of intraoperative bleeding, postoperative bleeding and the overall recovery of postpartum in the experimental group were better than those in the control group, and the coagulation function index was higher than that in the control group. There was a difference between the two groups (P < 0.05). The curative effect of the experimental group was better than that of the control group (P < 0.05). Conclusion: ergometrine treatment for postpartum hemorrhage caused by uterine atony can improve the curative effect, improve symptoms and reduce bleeding volume.
关键词	麦角新碱；宫缩乏力性产后出血；疗效
KeyWord	ergometrine; Postpartum hemorrhage due to uterine atony; curative effect
基金项目
页码	69-71

参考文献
相关文献

[1] 刘晓媛,徐小翠. 马来酸麦角新碱联合卡前列甲酯栓治疗宫缩乏力性产后出血的临床疗效[J]. 当代医学,2022,28(16):99-101.

[2] 李雪琳. 益气凉血安宫汤联合麦角新碱治疗宫缩乏力性产后出血的效果分析[J]. 实用中西医结合临床,2022,22(10):112-114.

[3] 赵荣,元玮玲,梁文娟. 麦角新碱治疗宫缩乏力性产后出血的临床效果及对凝血功能、应激反应的影响[J]. 临床医学研究与实践,2022,7(14):78-81.

[4] 李琳. 马来酸麦角新碱联合米索前列醇对宫缩乏力性产后出血产妇凝血功能的影响[J]. 中外医疗,2022,41(10):82-85.

[5] 史琳娜,王艳妮. 马来酸麦角新碱联合缩宫素预防宫缩乏力性产后出血的疗效及安全性观察[J]. 贵州医药,2022,46(01):94-95.

[6] 王瑞. 麦角新碱在宫缩乏力性产后出血治疗中的应用价值[J]. 中国现代药物应用,2022,16(01):199-201.

[7] 张歆悦,韩筱兰,陈晓红. 卡前列素氨丁三醇联合麦角新碱应用于宫缩乏力性产后出血的治疗效果及对凝血功能指标的影响[J]. 中外医学研究,2022,20(01):110-113.

[8] 蒋小辉. 麦角新碱与卡前列素氨丁三醇及缩宫素治疗阴道分娩宫缩乏力性产后出血的临床效果比较[J]. 临床合理用药杂志,2021,14(29):128-130.

[9] 李冉. 马来酸麦角新碱联合葡萄糖酸钙治疗宫缩乏力性产后出血疗效及对患者应激反应的影响[J]. 吉林医学,2021,42(08):1927-1929.

[10] 余淑勤,徐小翠,李梅荣. 缩宫素联合麦角新碱治疗宫缩乏力性产后出血的效果观察[J]. 药品评价,2021,18(09):549-551.

引用本文

马雅欣*. 麦角新碱在宫缩乏力性产后出血治疗中的价值 [J]. 国际医药研究前沿. 2022; 6; (5). 69 - 71.

文献评论

相关学者

相关机构